Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Covishield

Serum Institute Restarts Covishield Manufacturing: Adar Poonawalla

The company has availability of six million booster doses and adults must take the booster shot, he added

Read More

Cardiologist Deemed Covishield 'Worse In Cardiovascular Effects’

The Covid vaccine from Oxford/AstraZeneca is significantly worse than the mRNA jab from Pfizer in terms of cardiovascular effects, heart attacks, strokes and clotting issues in both younger and older adults, he said

Read More

Govt Panel Recommends Corbevax As Booster Dose For Adults

The COVID-19 Working Group (CWG), in its July 20 meeting, reviewed data of the double-blind randomized phase-3 clinical study which evaluated the immunogenicity and safety of booster dose of Corbevax vaccine when administered to COVID-19-negative adult volunteers of age 18-80 years previously vaccinated with two doses of either Covishield or Covaxin.

Read More

Covishield And Covaxin Doses To Cost Rs 225 Now In Private Hospitals

The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225

Read More

SII Urges Mandaviya To Reduce Gap Between 2nd, Precaution Dose Of Covishield From 9 To 3 Months

In a letter to Mandaviya, Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, is learnt to stated that the third dose of COVID-19 vaccine is being administered within 6 months of the second dose in various countries and this schedule is giving very good results to control the infection, an official source said.

Read More

Reports Claiming 50L Unused Covishield Doses May Go Waste By Month End 'Misleading': Govt

States were advised that they could try interventions such as administration of vaccine under Corporate Social Responsibility or vaccination at subsidised rates in private hospitals, the health ministry stated.

Read More

India's Expert Panel Advises Full Approval For Covishield, Covaxin

Covaxin and Covishield received emergency use authorisation in India in January 2021, with more than a combined 1.5 billion doses having been administered so far, according to government data.

Read More

Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin

Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.

Read More

Serum Institute Urges Govt To Fast-Track Movement Of Its COVID-19 Vaccine Covishield

The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.

Read More

Govt Allows Serum Institute To Export 50L Covishield Doses To 4 Nations

In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.

Read More

Serum Institute Of India Seeks Regular Marketing Authorisation From DCGI For Covishield

The cumulative COVID-19 vaccines administered in the country has exceeded 102.27 crore.

Read More

Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19

The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.

Read More

India Raises Concern Over UK's Non-Recognition Of Covishield, Says Its ‘Discriminating Policy’

"The non-recogition of Covishield is a discriminating policy and impacts our citizens travelling to the UK. The External Affairs Minister has raised the issue strongly with the new UK foreign secretary."

Read More

Calls For UK To Review COVID Vaccine Protocol For Indian Travellers

The current traffic light system of red, amber and green countries based on levels of COVID-19 risk will be scrapped and replaced with one red list only.

Read More

NTAGI Likely To Consider Reducing Gap Between Two Doses Of Covishield: Sources

The government in May had further extended the gap between the two doses of Covishield from 6-8 weeks to 12-16 weeks and said the decision to increase the gap was based on scientific evidence.

Read More